GlassScriptPhysician profile
Braedon Collins
NPI 1356725055
$9,669.44
in general payments reported to CMS, 2019-2025
45 companies · $1,574 in 2025
The $1,574 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,746 · 2020: $357 · 2021: $2,499 · 2022: $872 · 2023: $1,221 · 2024: $1,402 · 2025: $1,574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,196.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,466.56 | 2019-2025 | Lithovue, Ams 700, Lumenis Pulse 120h |
| Axonics, INC. | $1,681.66 | 2020-2023 | Axonics |
| Medtronic, INC. | $1,152.12 | 2021-2025 | Interstim, Altaviva, Signia |
| Procept Biorobotics Corporation | $643.14 | 2020-2024 | Aquabeam Robotic System, Aquabeam System |
| Teleflex LLC | $339.32 | 2021-2025 | Barrigel, Urolift |
| Agiliti Health, INC. | $269.60 | 2024-2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Coloplast Corp | $248.83 | 2019-2025 | Speedicath |
| Sumitomo Pharma America, INC. | $217.67 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $140.33 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $124.15 | 2020-2022 | |
| Dornier Medtech America, INC | $116.22 | 2019 | |
| Urogen Pharma, INC. | $79.11 | 2021-2025 | Jelmyto |
| Myovant Sciences INC. | $76.00 | 2021-2022 | |
| Pfizer INC. | $72.81 | 2023-2025 | |
| Urovant Sciences INC | $68.36 | 2021-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Braedon Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.